申请人:Yager Kraig
公开号:US20050250823A1
公开(公告)日:2005-11-10
Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.
由一种indazolyl基团和一种thiazolyl基团组成的化合物,特别是7-取代的3-(thiazol-2-yl)-1H-indazole化合物,其中indazolyl基团和thiazolyl基团各自独立地可以选择性地取代,可用于治疗或预防哺乳动物的细菌感染。这些化合物被认为通过抑制gyrase B的功能来发挥作用。